Lv1
84 积分 2023-07-14 加入
Molecular cloning and expression of a receptor for human tumor necrosis factor
2天前
已完结
Suvemcitug (APX003, BD0801), a novel humanized rabbit anti-VEGF mAb with 5-fold higher affinity and a non-overlapping epitope compared to bevacizumab
17天前
已关闭
A CTLA-4 recycling × TIGIT bispecific antibody enables selective depletion of tumor-infiltrating regulatory T cells
22天前
已关闭
LB368 / 12 - A first-in-class CTLA-4×TIGIT BsAb selectively targets tumor-associated Treg cells to improve the safety profile of CTLA-4 targeting therapy
22天前
已关闭
New target DDR1: A "double-edged sword" in solid tumors
29天前
已完结
Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer
1个月前
已完结
DDR1-targeted therapies: current limitations and future potential
1个月前
已完结
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
1个月前
已完结
Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor
1个月前
已完结
FLT3-Ligand Treatment of Humanized Mice Results in the Generation of Large Numbers of CD141+ and CD1c+ Dendritic Cells In Vivo
1个月前
已完结
皖公网安备34019202002308
